Fasenra (Benralizumab) Treatment for Severe Asthma
Fasenra (Benralizumab) FAQ
What is benralizumab (Fasenra®)?
Benralizumab (Fasenra®) as add-on maintenance treatment in adult patients with severe eosinophilic asthma inadequately controlled despite high-dose inhaled corticosteroids plus long-acting beta-agonists (June 2019) There can be variation in the licensing of different medicines containing the same drug.
What is the target of benralizumab?
The target of benralizumab is a protein called interleukin-5 receptor, which is found particularly on a type of white blood cell called an eosinophil. What Fasenra is used for Fasenra is used to treat severe eosinophilic asthma in adults. Eosinophilic asthma is a type of asthma where patients have too many eosinophils in the blood or lungs.
What is Fasenra used for?
FASENRA is a prescription medicine used with other asthma medicines for the maintenance treatment of asthma in people 12 years and older whose asthma is not controlled with their current asthma medicines. FASENRA is not used to treat other problems caused by eosinophils and is not used to treat sudden breathing problems.
Does benralizumab (Fasenra®) treat severe eosinophilic asthma?
Benralizumab for treating severe eosinophilic asthma (updated September 2019) Benralizumab (Fasenra®) as add-on maintenance treatment in adult patients with severe eosinophilic asthma inadequately controlled despite high-dose inhaled corticosteroids plus long-acting beta-agonists (June 2019)
What is the prescribing information for Fasenra?
See full prescribing information for FASENRA. FASENRA is an interleukin-5 receptor alpha-directed cytolytic monoclonal antibody (IgG1, kappa) indicated for the add-on maintenance treatment of patients with severe asthma aged 12 years and older, and with an eosinophilic phenotype.
What is the difference between Fasenra and benralizumab?
Last updated on Sep 25, 2023. What is Fasenra? Fasenra is a monoclonal antibody that affects the actions of the body's immune system. Benralizumab works by reducing levels of eosinophils, a certain type of white blood cell that may contribute to the symptoms of asthma.
Can Fasenra be used for eosinophilic asthma?
CLINICAL PARTICULARS Fasenra is indicated as an add-on maintenance treatment in adult patients with severe eosinophilic asthma inadequately controlled despite high-dose inhaled corticosteroids plus long-acting β-agonists (see section 5.1).
Fasenra (Benralizumab) References
If you want to know more about Fasenra (Benralizumab), consider exploring links below:
What Is Fasenra (Benralizumab)
- https://www.drugs.com/fasenra.html
- https://www.fasenra.com/
- https://bnf.nice.org.uk/drugs/benralizumab/
- https://patient-info.co.uk/fasenra-69731/patient-leaflet
- https://www.ema.europa.eu/en/medicines/human/EPAR/fasenra
- https://en.wikipedia.org/wiki/Benralizumab
- https://asthma.net/treatment/fasenra-benralizumab
Fasenra (Benralizumab) Information
- https://medicalinformation.astrazeneca-us.com/home/prescribing-information/fasenra.html
- https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761070s005lbl.pdf
- https://www.connect360asthma.co.uk/content/dam/intelligentcontent/brands/connect360asthma/en/helpfulresource/fasenra-pdfs/Fasenra_patient_information_leave_piece_print_digital_GB-44325.pdf
- https://www.medicines.org.uk/emc/files/pil.8918.pdf
- https://den8dhaj6zs0e.cloudfront.net/50fd68b9-106b-4550-b5d0-12b045f8b184/3647bed4-ce91-4fe7-9bc5-32dbee73f80a/3647bed4-ce91-4fe7-9bc5-32dbee73f80a_viewable_rendition__v.pdf
Explore Related Topics
The Role of Monoclonal Antibodies in Pediatric Asthma Treatment
Discussing the use of monoclonal antibodies in treating severe asthma among children, share your concerns, experiences, or questions.
Monoclonal Antibodies and Asthma: Debunking Myths
There are many myths surrounding the use of monoclonal antibodies in asthma treatment. Let's debunk these myths and spread factual information.
How Immunotherapy for Asthma Fits into Long-term Management Plans
Discuss how immunotherapy integrates with other asthma management plans for long-term control and quality of life improvements. Share tips and strategies.
Understanding the Risks vs. Benefits of Immunotherapy for Asthma
Weigh the risks against the benefits of undergoing immunotherapy for asthma. Share resources, expert opinions, and personal viewpoints to help others make informed decisions.
The Role of Immunotherapy in Childhood Asthma Control
Exploring the benefits and considerations of using immunotherapy for managing asthma in allergic children. Could allergy shots be the shot at relief your child needs?
Can Monoclonal Antibodies Improve Quality of Life for Severe Asthma Patients?
If you or someone you know has experienced the impact of monoclonal antibodies on severe asthma, share your stories here. Let's discuss the quality of life improvements.
Who is Eligible for Asthma Immunotherapy?
Explore the criteria that determine whether a patient with asthma is a good candidate for immunotherapy. Discuss the factors that doctors consider before recommending this treatment.